Vietnam imported pharmaceutical products to the tune of US$350 million in October, down 15.56 percent over September, according to preliminary data from Vietnam’s General Department of Customs.
Year to date, Vietnam had imported US$3,561 million worth of pharmaceutical products by the end of October.
In October, Vietnam’s top supplier of pharmaceutical products was the USA, accounting for US$71 million worth. This was up 9.87 percent over September. Year to date, the USA has shipped US$446 million worth of pharmaceutical products to Vietnam.
After the USA, France was the next biggest supplier. It shipped US$41 million worth of pharmaceutical products to Vietnam in October, a fall of 22.02 percent. Its total for the year to date is now sitting at US$418 million.
Germany was also a major supplier, shipping US$31 million worth of pharmaceutical products to Vietnam in October. This was a fall of 11.58 percent, for a total of US$344 million for the year.
Rounding out the top five was Italy with US$24 million, a -1.14 percent change month-on-month, for a total of US$251 million for the year, and India with US$23 million, a -2.04 percent change for a total of US$246 million.
Learn more about accessing Vietnam’s consumer market→
Vietnam imports of pharmaceutical products in October, US$millions
| October | September | MoM | YTD | |
| Total | 350.02 | 414.51 | -15.56% | 3,560.53 |
| Other | 96.43 | 140.80 | -31.51% | 1,146.55 |
| USA | 71.03 | 64.65 | 9.87% | 445.95 |
| France | 40.54 | 51.99 | -22.02% | 417.66 |
| Germany | 30.52 | 34.52 | -11.58% | 343.75 |
| Italy | 23.54 | 23.81 | -1.14% | 250.87 |
| India | 23.36 | 23.84 | -2.04% | 245.55 |
| Belgium | 19.48 | 34.11 | -42.88% | 252.06 |
| South Korea | 15.64 | 13.70 | 14.16% | 113.80 |
| UK | 11.04 | 8.37 | 31.97% | 75.34 |
| Ireland | 9.35 | 8.41 | 11.23% | 163.68 |
| Switzerland | 9.06 | 10.29 | -11.94% | 105.31 |
| Spain | 8.23 | 17.61 | -53.26% | 101.92 |
| Austria | 7.11 | 12.97 | -45.22% | 85.42 |
| Japan | 7.05 | 3.49 | 102.10% | 50.41 |
| China | 5.65 | 5.85 | -3.54% | 48.14 |
| Thailand | 5.15 | 4.63 | 11.12% | 58.95 |
| Indonesia | 3.77 | 1.14 | 230.47% | 16.26 |
| Netherlands | 3.57 | 6.94 | -48.60% | 76.93 |
| Australia | 3.24 | 2.91 | 11.28% | 41.97 |
| Malaysia | 2.94 | 1.26 | 133.67% | 9.39 |
| Sweden | 2.89 | 28.19 | -89.76% | 138.10 |
| Cyprus | 2.54 | 1.30 | 94.91% | 20.99 |
| Poland | 2.51 | 2.77 | -9.40% | 37.88 |
| Hungary | 2.40 | 1.27 | 89.13% | 33.96 |
| Taiwan | 1.82 | 1.62 | 12.44% | 20.63 |
| Turkey | 1.40 | 1.70 | -17.13% | 19.84 |
| Canada | 1.27 | 1.04 | 21.97% | 14.36 |
| Bangladesh | 0.96 | 0.85 | 12.03% | 8.54 |
| Denmark | 0.93 | 5.64 | -83.48% | 23.72 |
| Lithuania | 0.89 | 0.45 | 98.31% | 4.01 |
| Singapore | 0.73 | 1.88 | -61.09% | 12.91 |
| Pakistan | 0.52 | 0.40 | 28.47% | 6.85 |
| Russia | 0.40 | 6.44 | -93.76% | 38.61 |
| Philippines | 0.13 | 0.15 | -15.28% | 0.52 |
| Argentina | 0.03 | 0.83 | -96.23% | 5.11 |
Listed pharmaceutical products companies
Ben Tre Pharmaceutical JSC
Ben Tre Pharmaceutical JSC (DBT) produces and distributes generic drugs, supplements, and medical products across Vietnam.
DBT closed at VND 11,300 on Thursday down 0.05 percent with 10,000 shares traded, worth VND 11 million.
Foreign ownership in DBT is currently capped at 0.0 percent, with current foreign ownership sitting at 0.0 percent.
Cuu Long Pharmaceutical Joint Stock Corporation
Cuu Long Pharmaceutical Joint Stock Corporation (DCL) manufactures and distributes pharmaceutical and healthcare products under the Traphaco Group.
DCL closed at VND 38,500 on Thursday up 2.25 percent with 21,322,000 shares traded, worth VND 81,316 million.
Foreign ownership in DCL is currently capped at 0.0 percent, with current foreign ownership sitting at 0.0 percent.
DHG Pharmaceutical Joint Stock Company
DHG Pharmaceutical Joint Stock Company (DHG) manufactures, markets, and distributes branded generic drugs and healthcare products nationwide.
DHG closed at VND 102,600 on Thursday down 0.2 percent with 31,000 shares traded, worth VND 319 million.
Foreign ownership in DHG is currently capped at 100.0 percent, with current foreign ownership sitting at 53.9 percent.
Domesco Medical Import Export JSC
Domesco Medical Import Export JSC (DMC) manufactures and distributes pharmaceuticals, supplements, and medical equipment in Vietnam.
DMC closed at VND 58,500 on Thursday down 0 percent with 0 shares traded, worth VND 0 million.
Foreign ownership in DMC is currently capped at 100.0 percent, with current foreign ownership sitting at 56.7 percent.
Explore opening a trading account in Vietnam→
Vietnam pharmaceutical products news
Pharmacy profits
Vietnam’s pharmaceutical sector continues to post strong profits, but broader policy and structural factors pose challenges to sustaining momentum, Tuoi Tre was reporting late last month.
Price adjustments, new tax rules, and the rollout of the two-tier local government model have created temporary slowdowns in hospital and retail drug demand.
Rising logistics and compliance costs, along with regulatory uncertainty in drug pricing and licensing, remain key constraints even as domestic healthcare demand and pharmacy networks expand steadily, the publication said.
See the latest Vietnam news headlines→
Vietnam’s pharmaceutical products industry
Vietnam’s pharmaceutical products industry is expanding on the back of rising healthcare demand and a growing middle class.
Local manufacturers focus on generics, while multinational firms dominate patented and high-value medicines.
Regulatory reforms are improving market access, though approval timelines and pricing rules remain constraints.